Cronos Group Inc. (CRON)
NASDAQ: CRON · IEX Real-Time Price · USD
2.610
-0.090 (-3.33%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $1.03 billion as of March 28, 2024. Its market cap has increased by 39.44% in one year.
Market Cap
1.03B
Enterprise Value
163.43M
1-Year Change
39.44%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $1.03B, a decrease of -9.54%. That is a compound annual growth rate of -1.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 1.03B | 2.27% |
Mar 26, 2024 | 1.01B | 6.02% |
Mar 25, 2024 | 949.40M | -4.60% |
Mar 22, 2024 | 995.20M | 9.21% |
Mar 21, 2024 | 911.30M | 1.27% |
Mar 20, 2024 | 899.90M | 3.06% |
Mar 19, 2024 | 873.20M | 2.69% |
Mar 18, 2024 | 850.30M | 6.19% |
Mar 15, 2024 | 800.70M | 6.05% |
Mar 14, 2024 | 755.00M | -1.97% |
Mar 13, 2024 | 770.20M | 2.53% |
Mar 12, 2024 | 751.20M | -0.50% |
Mar 11, 2024 | 755.00M | -0.50% |
Mar 8, 2024 | 758.80M | 1.01% |
Mar 7, 2024 | 751.20M | 0.52% |
Mar 6, 2024 | 747.30M | -0.52% |
Mar 5, 2024 | 751.20M | 2.08% |
Mar 4, 2024 | 735.90M | -4.45% |
Mar 1, 2024 | 770.20M | -2.89% |
Feb 29, 2024 | 793.10M | -7.92% |
Feb 28, 2024 | 861.30M | -1.75% |
Feb 27, 2024 | 876.60M | 2.68% |
Feb 26, 2024 | 853.70M | 0.45% |
Feb 23, 2024 | 849.90M | 0.45% |
Feb 22, 2024 | 846.10M | 1.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Zentalis Pharmaceuticals | 999.12M |
Relay Therapeutics | 993.03M |
Spyre Therapeutics | 990.58M |
Bicycle Therapeutics | 963.30M |
Innoviva | 954.10M |
Pacific Biosciences of California | 943.19M |
ARS Pharmaceuticals | 942.82M |
National Research | 941.77M |